JP6470289B2 - カンナビノイド化合物の組成物、その製造及び使用 - Google Patents
カンナビノイド化合物の組成物、その製造及び使用 Download PDFInfo
- Publication number
- JP6470289B2 JP6470289B2 JP2016539439A JP2016539439A JP6470289B2 JP 6470289 B2 JP6470289 B2 JP 6470289B2 JP 2016539439 A JP2016539439 A JP 2016539439A JP 2016539439 A JP2016539439 A JP 2016539439A JP 6470289 B2 JP6470289 B2 JP 6470289B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- composition
- compounds
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/50—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions decreasing the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13182788.3 | 2013-09-03 | ||
| EP13182788.3A EP2842933B1 (de) | 2013-09-03 | 2013-09-03 | Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung |
| PCT/EP2014/063872 WO2015032519A1 (de) | 2013-09-03 | 2014-06-30 | Mischungen cannabinoider verbindungen, deren herstellung und verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016531919A JP2016531919A (ja) | 2016-10-13 |
| JP6470289B2 true JP6470289B2 (ja) | 2019-02-13 |
Family
ID=49117691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016539439A Active JP6470289B2 (ja) | 2013-09-03 | 2014-06-30 | カンナビノイド化合物の組成物、その製造及び使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9670133B2 (enExample) |
| EP (2) | EP2842933B1 (enExample) |
| JP (1) | JP6470289B2 (enExample) |
| CN (1) | CN105517989B (enExample) |
| BR (1) | BR112016004675B1 (enExample) |
| ES (2) | ES2547354T3 (enExample) |
| WO (1) | WO2015032519A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3150264A1 (de) * | 2015-09-30 | 2017-04-05 | Bionorica Ethics GmbH | Vakuumdestillation zur anreicherung von cbd |
| DK3455213T3 (da) | 2016-05-13 | 2022-03-07 | Symrise Ag | Fremgangsmåde til at oprense cannabinoid-forbindelser via simulated moving bed-kromatografi |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| CN106810426B (zh) * | 2016-12-29 | 2020-05-08 | 暨明医药科技（苏州）有限公司 | 一种大麻二酚的合成方法 |
| WO2018209143A1 (en) * | 2017-05-10 | 2018-11-15 | Baymedica, Inc. | Recombinant production systems for prenylated polyketides of the cannabinoid family |
| US11440870B2 (en) | 2017-06-20 | 2022-09-13 | University Of Guelph | Cannabidiolic acid esters compositions and uses thereof |
| CA3107566A1 (en) | 2017-08-07 | 2019-02-14 | Enantia, S.L. | A cocrystal of 2-[(1r,6r)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol |
| EP3668829A4 (en) * | 2017-08-16 | 2021-05-19 | The University Of Sydney | SYNTHESIS OF PHYTOCANNABINOIDS INCLUDING A DEMETHYLATION STEP |
| CN111183135A (zh) * | 2017-08-16 | 2020-05-19 | 悉尼大学 | 包括脱羧步骤的植物大麻素的合成 |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| AU2019217673A1 (en) | 2018-02-07 | 2020-09-24 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
| US20220331235A1 (en) * | 2018-02-19 | 2022-10-20 | Fp Nutraceuticals, Llc | Compositions for oral microadhesive dosage forms |
| ES2992095T3 (es) | 2018-05-03 | 2024-12-09 | Scf Pharma Inc | Monoglicéridos de ácidos grasos poliinsaturados, composiciones y uso de los mismos para modular la composición de la microbiota de un sujeto |
| WO2019234728A1 (en) * | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
| CN112292368B (zh) * | 2018-06-28 | 2024-02-02 | 西姆莱斯有限公司 | （+）-大麻素类的合成及其治疗作用 |
| US20200035118A1 (en) | 2018-07-27 | 2020-01-30 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
| US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
| CA3073093A1 (en) | 2018-08-03 | 2020-02-06 | Biomass Oil Separation Solutions, Llc | Processes and apparatus for extraction of substances and enriched extracts from plant material |
| US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| EP3873459A1 (en) | 2018-10-31 | 2021-09-08 | Enantia, S.L. | Solid compositions of cocrystals of cannabinoids |
| EP3653596A1 (en) * | 2018-11-14 | 2020-05-20 | Indena S.p.A. | Continuous flow synthesis of cannabidiol |
| JP2022516845A (ja) * | 2018-12-25 | 2022-03-03 | イーピーエム（アイピー）， インコーポレイテッド | 化粧品用または食用組成物のためのカンナビジオール酸エステル |
| CN109734591A (zh) * | 2018-12-26 | 2019-05-10 | 江苏暨明医药科技有限公司 | 一种大麻二酚中间体及其制备方法与及应用 |
| CN113840598B (zh) | 2019-03-12 | 2024-07-05 | Epm(Ip)公司 | 大麻素酸酯组合物及其用途 |
| WO2020198874A1 (en) * | 2019-04-04 | 2020-10-08 | Scf Pharma Inc. | Cannabidiolic acid monoglycerides, derivatives, and uses thereof |
| WO2020214574A1 (en) | 2019-04-15 | 2020-10-22 | Trustees Of Boston University | One-step flow-mediated synthesis of cannabidiol (cbd) and derivatives |
| KR20220007078A (ko) * | 2019-05-10 | 2022-01-18 | 베누비아 매뉴팩처링, 엘엘씨 | 칸나비디올 또는 칸나비디바린의 제조 방법 및 칸나비디올 또는 칸나비디바린 제조의 중간체 |
| CN111943813B (zh) * | 2019-05-17 | 2023-04-14 | 上海特化医药科技有限公司 | 大麻二酚类化合物的制备方法 |
| GB201910389D0 (en) * | 2019-07-19 | 2019-09-04 | Gw Pharma Ltd | Novel compounds, methods for their manufacture, and uses thereof |
| US12226390B2 (en) | 2019-07-21 | 2025-02-18 | Scf Pharma Inc. | Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof |
| US10799546B1 (en) | 2019-07-26 | 2020-10-13 | Biomass Oil Separation Solutions, Llc | Modular, integrated process and apparatus for extracting, refining and remediating active substances from plant material |
| JP2022551066A (ja) * | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| GB2588457B (en) * | 2019-10-25 | 2022-12-21 | Gw Res Ltd | Cannabinoid compound |
| GB2588456B (en) * | 2019-10-25 | 2023-02-01 | Gw Res Ltd | Cannabinoid compound |
| JP2023512578A (ja) * | 2020-02-06 | 2023-03-27 | ロンドン ファーマシューティカルズ アンド リサーチ コーポレーション | Ｃアナビンオイド硫酸エステル、その塩及び用途 |
| WO2021207605A1 (en) * | 2020-04-10 | 2021-10-14 | 3Bc, Llc | Methods for preparing cannabinoids and related instruments |
| GB202016536D0 (en) * | 2020-10-19 | 2020-12-02 | Aesica Pharmaceuticals Ltd | Process |
| CN114507153B (zh) * | 2020-11-17 | 2025-06-24 | 中国科学院上海药物研究所 | 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用 |
| EP4267122A4 (en) * | 2020-12-24 | 2024-04-24 | Buzzelet Development And Technologies Ltd | Compositions comprising cannabinoid acid esters |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH473075A (de) * | 1966-11-04 | 1969-05-31 | Theodor Dr Petrzilka | Verfahren zur Herstellung von in 2-Stellung substituierten Resorcinderivaten |
| US5342971A (en) | 1992-12-29 | 1994-08-30 | The Australian National University | Process for the preparation of dibenzo[b,d]pyrans |
| CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
| DE102005028937B4 (de) | 2005-06-22 | 2009-07-23 | Bionorica Ag | Verfahren zur Herstellung von Dronabinol |
| EP2578577A1 (en) * | 2005-09-29 | 2013-04-10 | Albany Molecular Research, Inc. | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof |
| DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
-
2013
- 2013-09-03 EP EP13182788.3A patent/EP2842933B1/de not_active Not-in-force
- 2013-09-03 ES ES13182788.3T patent/ES2547354T3/es active Active
-
2014
- 2014-06-30 ES ES14739086T patent/ES2738332T3/es active Active
- 2014-06-30 WO PCT/EP2014/063872 patent/WO2015032519A1/de not_active Ceased
- 2014-06-30 EP EP14739086.8A patent/EP3041815B1/de active Active
- 2014-06-30 US US14/653,044 patent/US9670133B2/en active Active
- 2014-06-30 BR BR112016004675-7A patent/BR112016004675B1/pt active IP Right Grant
- 2014-06-30 JP JP2016539439A patent/JP6470289B2/ja active Active
- 2014-06-30 CN CN201480048263.8A patent/CN105517989B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9670133B2 (en) | 2017-06-06 |
| EP3041815A1 (de) | 2016-07-13 |
| ES2738332T3 (es) | 2020-01-22 |
| CN105517989B (zh) | 2018-06-01 |
| EP3041815B1 (de) | 2019-04-03 |
| US20150336874A1 (en) | 2015-11-26 |
| ES2547354T3 (es) | 2015-10-05 |
| JP2016531919A (ja) | 2016-10-13 |
| EP2842933B1 (de) | 2015-07-29 |
| BR112016004675A2 (enExample) | 2017-08-01 |
| EP2842933A1 (de) | 2015-03-04 |
| CN105517989A (zh) | 2016-04-20 |
| WO2015032519A1 (de) | 2015-03-12 |
| BR112016004675B1 (pt) | 2023-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6470289B2 (ja) | カンナビノイド化合物の組成物、その製造及び使用 | |
| US11964955B2 (en) | Mixtures of cannabinoid compounds, and production and use thereof | |
| JP6215230B2 (ja) | イオンチャネルのモジュレーターとしてのピラン−スピロ環式ピペリジンアミド | |
| EP2943467B1 (en) | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases | |
| JPH09503771A (ja) | 治療剤 | |
| KR20200133259A (ko) | Kv7 채널 활성화제 조성물 및 이의 사용 방법 | |
| MX2011001392A (es) | Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de crf1. | |
| JP2003511469A (ja) | 抹消カンナビノイド受容体（ｃｂ２）選択的配位子 | |
| BRPI0608819B1 (pt) | formas cristalinas de um derivado de imidazol | |
| CN104161759B (zh) | 阿那格雷及其衍生物的抗肿瘤用途 | |
| US7071205B2 (en) | 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds | |
| WO2020001770A1 (en) | Synthesis of (+)-cannabinoids and their therapeutic effects | |
| CN108640921A (zh) | 一种枸橼酸托法替布的制备方法 | |
| JP2009538270A (ja) | 細胞複製破壊剤および病的状態を阻止する際のその使用 | |
| AU2006291060B2 (en) | Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof | |
| AU2006291059A1 (en) | Salicylate and gentisate salts of a piperazine compound | |
| Edery | US PATENT D ()(" UMENTS | |
| US10272124B2 (en) | Use of helminthostachys, ugonins or flavone-based compounds for the treatment or prevention of metabolic diseases | |
| MX2008003258A (en) | Salicylate and gentisate salts of a piperazine compound | |
| MX2008003125A (en) | Glucuronate salt of a piperazine compound | |
| WO2011047597A1 (zh) | 二羟基苯并吡喃酮化合物、其药物组合物及其预防和治疗骨折和骨质疏松的应用 | |
| HK1120497A (en) | Salicylate and gentisate salts of a piperazine compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170629 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180423 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180723 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190110 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190117 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6470289 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |